CompoAtlas

HÉPATIQUE

Food supplement declared in France, declaration No 2024-4-1480

HÉPATIQUE is a food supplement declared in France. Status: retiré du marché le 5 June 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
LUSTREL LABORATOIRES
Status
Retiré du marché le 5 June 2026
Form
Gélule
Daily dose
1 gélule par jour
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Ulcère (estomac ou duodenum)

Declaration 141297, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Silybum marianum (L.) Gaertn.FruitAutre extrait sec250 mg
Taraxacum campylodes G.E.HaglundRacineExtrait sec aqueux100 mg

Other active ingredients

NamePer day
L-Ornithine HCLnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E553b, E470b

Other ingredients

gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux femmes enceintes ou allaitantes. Déconseillé en cas d'allergie croisée connue en particulier à la famille des Asteraceae. Déconseillé en cas d’obstructions biliaires, d’insuffisance cardiaque ou rénale.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Enter to analyse, Shift+Enter for a new line